GB517425A - X-ray contrast media - Google Patents

X-ray contrast media

Info

Publication number
GB517425A
GB517425A GB2209138A GB2209138A GB517425A GB 517425 A GB517425 A GB 517425A GB 2209138 A GB2209138 A GB 2209138A GB 2209138 A GB2209138 A GB 2209138A GB 517425 A GB517425 A GB 517425A
Authority
GB
United Kingdom
Prior art keywords
octadecenyl
ray
iodobenzoate
triiodobenzoate
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2209138A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB2209138A priority Critical patent/GB517425A/en
Publication of GB517425A publication Critical patent/GB517425A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

517,425. Contrast media for X-ray photographs. BRANSCOMBE, D. J., and IMPERIAL CHEMICAL INDUSTRIES, LTD. July 25, 1938, No. 22091. [Class 81 (i)] Compositions suitable for use as X-ray contrast agents comprise dispersions in water or aqueous media or solutions in a bland oil of esters of saturated or unsaturated aliphatic alcohols with mono- or poly-iodo aromatic carbocyclic or heterocyclic carboxylic acids. X-ray photographs are made by introducing the compositions by direct administration or bv intravenous injection into the part of the body concerned followed by irradiation and the taking of the X-ray photograph. Suitable esters which may be made by the process of Specification 517,382, [Group IV], include octadecenyl 2 : 5-diiodobenzoate, octadecenyl 2 : 3: 5-triiodobenzoate, octadecenyl 3 : 4: 5-triiodophenylacetate, octadecenyl o-iodobenzoate, dodecyl o-iodobenzoate, and cetyl o-iodobenzoate. In an example octadecenyl 2 : 3 : 5- triiodobenzoate is directly introduced into the trachea of a human subject and the X-ray photograph then taken shows a sharply defined image of the bronchial tree. The Provisional Specification also refers to the visual observation of the X-ray image on a fluorescent screen.
GB2209138A 1938-07-25 1938-07-25 X-ray contrast media Expired GB517425A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2209138A GB517425A (en) 1938-07-25 1938-07-25 X-ray contrast media

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2209138A GB517425A (en) 1938-07-25 1938-07-25 X-ray contrast media

Publications (1)

Publication Number Publication Date
GB517425A true GB517425A (en) 1940-01-30

Family

ID=10173771

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2209138A Expired GB517425A (en) 1938-07-25 1938-07-25 X-ray contrast media

Country Status (1)

Country Link
GB (1) GB517425A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2548852A (en) * 1949-01-29 1951-04-17 Sterling Drug Inc Alkoxyalkyl esters of iodo-alkoxy substituted phenyl acetic acids
US2572828A (en) * 1947-11-24 1951-10-30 Sterling Drug Inc Alkoxyalkyl esters of monoiodomono-alkoxybenzoic acids
US2612517A (en) * 1947-11-24 1952-09-30 Sterling Drug Inc Alkoxyalkyl iodobenzoates
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
US2680089A (en) * 1950-02-13 1954-06-01 Lowy Benno Barium sulfate suspension
DE962545C (en) * 1952-08-17 1957-04-25 Schering Ag X-ray contrast media
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2572828A (en) * 1947-11-24 1951-10-30 Sterling Drug Inc Alkoxyalkyl esters of monoiodomono-alkoxybenzoic acids
US2612517A (en) * 1947-11-24 1952-09-30 Sterling Drug Inc Alkoxyalkyl iodobenzoates
US2548852A (en) * 1949-01-29 1951-04-17 Sterling Drug Inc Alkoxyalkyl esters of iodo-alkoxy substituted phenyl acetic acids
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
US2680089A (en) * 1950-02-13 1954-06-01 Lowy Benno Barium sulfate suspension
DE962545C (en) * 1952-08-17 1957-04-25 Schering Ag X-ray contrast media
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium

Similar Documents

Publication Publication Date Title
GB517425A (en) X-ray contrast media
Cushing An Address on Acromegaly from a Surgical Standpoint: Part I
GB487471A (en) Improvements in hardening photographic emulsions
GB600653A (en) Process for producing unsaturated aliphatic compounds
Nagler A cultural reaction for the early diagnosis of Clostridium oedematiens infection.
GB936339A (en) Process for extracting carboxylic acids produced by fermentation
GB425216A (en) Improvements in or relating to a method of manufacturing bacterial solutions
GB480721A (en) X-ray contrast media and the production of x-ray photographs
Melemey et al. Infection of kittens with Endamoeba histolytica by direct injection of cultures into the ileum
DE859056C (en) Process for the manufacture of penicillin
DE407669C (en) Process for the production of ether derivatives of nuclear mercured aromatic oxycarboxylic acids
AT218175B (en) X-ray contrast medium to visualize the biliary tract
GB561735A (en) Synthetic rubber
DE910467C (en) Process for the preparation of solutions for blood substitutes, blood fluid substitutes, plasma and serum substitutes
Panja et al. Treatment of Psoriasis
GB499765A (en) Improvements in or relating to medical injections
Happold et al. The Lipolytic Activity of Tubercular Guinea-Pig's Tissues. III.—Variation of Activity with the Spread of the Disease
CH175026A (en) Process for the preparation of a benzimidazolium derivative.
Greenhill An effective treatment of trichomonas vaginalis vaginitis: Dubois, P.: Schweiz. med. Wchnschr. 74: 1944, 1944
GB486756A (en) Improvements in and relating to remedies for bacterial infections
GB474097A (en) Process for the purification of synthetic camphor
YUN STUDIES ON THE PRODUCTION OF AGGLUTININS FOR TYPHOID BACILLI BY INTRAHEPATIC VACCINATION
FR809500A (en) Process for extracting the anhydride resulting from the thermal decomposition of organic acids, and in particular acetic acid
GB574736A (en) Improved anti-dimming material
Banks Soluble Sulphonamide Compounds